These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3735314)

  • 1. Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids.
    Johnson RA; Nidy EG; Aiken JW; Crittenden NJ; Gorman RR
    J Med Chem; 1986 Aug; 29(8):1461-8. PubMed ID: 3735314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
    Tai HH; Lee N; Tai CL
    Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase].
    Nakazawa M; Iizuka K; Ujiie A; Hiraku S; Ohki S
    Yakugaku Zasshi; 1994 Dec; 114(12):911-33. PubMed ID: 7869235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of thromboxane synthetase inhibitors.
    Aiken JW
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():253-8. PubMed ID: 6221532
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 1. (+/-)-(3-pyridinylbicycloheptyl)alkanoic acids.
    Bhagwat SS; Gude C; Cohen DS; Lee W; Furness P; Clarke FH
    J Med Chem; 1991 Jun; 34(6):1790-7. PubMed ID: 1829485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 3. Pyridinylalkyl-substituted 8-[(arylsulfonyl)amino]octanoic acids.
    Main AJ; Bhagwat SS; Boswell C; Goldstein R; Gude C; Cohen DS; Furness P; Lee W; Louzan M
    J Med Chem; 1992 Nov; 35(23):4366-72. PubMed ID: 1447737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
    J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1,4-dihydropyridines combining Ca2+ antagonism and thromboxane A2 synthase inhibition.
    Cozzi P; Carganico G; Fusar D; Grossoni M; Menichincheri M; Pinciroli V; Tonani R; Vaghi F; Salvati P
    J Med Chem; 1993 Oct; 36(20):2964-72. PubMed ID: 8411014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective thromboxane synthetase inhibitors. 3. 1H-imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene-, and indole-2- and -3-carboxylic acids.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1986 Sep; 29(9):1637-43. PubMed ID: 3746813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.
    Main AJ; Goldstein R; Cohen DS; Furness P; Lee W
    J Med Chem; 1992 Nov; 35(23):4362-5. PubMed ID: 1447736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I
    J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ridogrel: a selective inhibitor of the cytochrome P450-dependent thromboxane synthesis.
    Vanden Bossche H; Willemsens G; Bellens D; Janssen PA
    Biochem Pharmacol; 1992 Feb; 43(4):739-44. PubMed ID: 1540227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane synthetase inhibitors: design and synthesis of a novel series of omega-pyridylalkenoic acids.
    Terao S; Kato K; Ohkawa S; Terashita Z; Nishikawa K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():315-7. PubMed ID: 2936112
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. VI. Indazole derivatives.
    Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):332-4. PubMed ID: 7728936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of thromboxane synthetase.
    Takami M; Tsukada W
    Pharmacol Res; 1998 Aug; 38(2):133-9. PubMed ID: 9721601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor.
    Fitzpatrick F; Gorman R; Bundy G; Honohan T; McGuire J; Sun F
    Biochim Biophys Acta; 1979 May; 573(2):238-44. PubMed ID: 375987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thromboxane synthase inhibitors on renal function.
    Jackson EK; Goto F; Uderman HD; Workman RJ; Herzer WA; FitzGerald GA; Branch RA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):183-90. PubMed ID: 3285227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.